Embody No Membership Fee: Plans and Costs Examined (2026) — 2026

Last reviewed: September 4, 2026 Last updated: September 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Embody is a good fit if you want no membership fee, flat monthly billing, and are comfortable with injection-only semaglutide or tirzepatide. Its standard month-to-month rates are $299 for semaglutide and $349 for tirzepatide, verified at checkout in July 2026, and it includes 24/7 clinical chat support plus a 6-month money-back guarantee. Embody does not charge a membership fee on top of the medication price and does not bill you until your prescription and dose are approved.

PlexusDx also charges no membership fee and offers the same cancel-anytime monthly billing structure, but at lower standard rates—$189/month for semaglutide injection and $289/month for tirzepatide injection—and adds oral and microdose formats that Embody does not offer. Both programs bundle provider visits, medication, and shipping into a single monthly price; the economic difference is $110/month on semaglutide and $60/month on tirzepatide when comparing month-to-month rates.

At-a-glance comparison

All prices verified at checkout July 2026. MTM = month-to-month. Embody multi-month prepaid rates not published as of this capture.

Normalized pricing: month-to-month rates and 12-month cost

Both programs charge no membership fee and bill month-to-month at a flat rate that covers the provider visit, prescription, medication, and shipping. Neither charges until a licensed provider approves your prescription. We normalize to 12-month totals using only the standard ongoing month-to-month rates verified at checkout in July 2026.

Embody (injection only, standard monthly rates)

• Semaglutide injection: $299/month × 12 = $3,588/year (our calculation)
• Tirzepatide injection: $349/month × 12 = $4,188/year (our calculation)

Embody does not publish multi-month prepaid rates. The $299 and $349 figures are its standard ongoing month-to-month prices captured at checkout July 21, 2026. The program states "same price at every dose," meaning your monthly bill stays flat regardless of titration.

PlexusDx (injection, standard monthly rates)

• Semaglutide injection: $189/month × 12 = $2,268/year (our calculation)
• Tirzepatide injection: $289/month × 12 = $3,468/year (our calculation)

PlexusDx also offers lower committed-term rates: 3-month semaglutide at $169/month ($2,028/year as a prepaid per-month equivalent, our calculation) and 6-month semaglutide at $149/month ($1,788/year as a prepaid per-month equivalent, our calculation). Because Embody's multi-month rates are not published, we cannot perform a like-for-like comparison at the 3- or 6-month tier; the month-to-month figures above are the only apples-to-apples data available.

Annual difference (month-to-month rates)

• Semaglutide: $3,588 (Embody) − $2,268 (PlexusDx) = $1,320/year lower at PlexusDx (our calculation)
• Tirzepatide: $4,188 (Embody) − $3,468 (PlexusDx) = $720/year lower at PlexusDx (our calculation)

If you commit to 6 months with PlexusDx, the semaglutide gap widens to $1,800/year (Embody $3,588 vs PlexusDx prepaid equivalent $1,788, our calculation), but that comparison assumes Embody's 6-month rate—if it exists—is no lower than its month-to-month rate. We cannot verify that assumption because Embody's committed-term pricing is not published.

Decision factors: what Embody offers and where it has gaps

Embody's advantages

6-month money-back guarantee. Embody offers a 6-month satisfaction refund, captured at its site in July 2026. We did not capture the full terms—whether it requires return of unused medication, covers only certain months, or imposes restocking fees—but the headline promise is clear. PlexusDx does not offer a money-back guarantee of any duration.

24/7 clinical chat support. Embody includes round-the-clock chat access to its clinical team and states "unlimited provider visits" are included in the monthly price. If you anticipate needing frequent check-ins or prefer asynchronous text-based communication at odd hours, this is an advantage over PlexusDx's model, which centers on a named Doctor of Pharmacy (Dr. Jayden Lee) and includes one free 1:1 check-in but does not advertise 24/7 chat availability.

Flat-rate simplicity. Embody's "same price at every dose" messaging means your bill stays $299 or $349 regardless of titration schedule. This is also true of PlexusDx's flat monthly rates, but Embody emphasizes the predictability explicitly in its marketing.

Embody's gaps

No oral or microdose formats. As of July 2026, Embody offers injection-only semaglutide and tirzepatide. If you want oral administration to avoid needles or a lower-dose maintenance protocol after initial weight loss, you must look elsewhere. PlexusDx offers oral semaglutide at $289/month, oral tirzepatide at $349/month, and a microdose GLP-1 injection at $129/month for long-term weight maintenance.

Higher standard rates. Embody's month-to-month rates are $110/month higher for semaglutide and $60/month higher for tirzepatide than PlexusDx's standard injection rates. Over 12 months, that compounds to $1,320 and $720 respectively (our calculation). Embody may offer unpublished multi-month prepaid rates that narrow this gap, but we have no evidence of them as of July 2026.

No genetics layer. Embody does not offer medication-metabolism testing. PlexusDx includes an optional genetics add-on ($298 standalone, $99 for program members) that tests how your body metabolizes medications. The test does not select or predict a medication; your provider decides. If you are interested in understanding your metabolic profile for broader medication decisions beyond GLP-1, Embody does not provide that option.

Choose Embody if…

• You want a 6-month money-back guarantee and are willing to pay a higher monthly rate for that safety net.
• You value 24/7 clinical chat support and anticipate needing asynchronous access outside business hours.
• You are comfortable with injection-only administration and do not need oral or microdose formats.
• You prefer a program that emphasizes unlimited provider visits as part of its flat monthly price.
• The $110–$60/month premium over PlexusDx's standard rates is acceptable in exchange for the guarantee and round-the-clock chat access.

Where PlexusDx fits

PlexusDx is a better fit if lower monthly cost is your priority and you do not require a money-back guarantee. At $189/month for semaglutide injection and $289/month for tirzepatide injection (month-to-month rates verified July 2026), PlexusDx charges $1,320 to $720 less per year than Embody for the same compounds and routes (our calculation). It also offers five protocols—semaglutide and tirzepatide in both injection and oral forms, plus a $129/month microdose injection—giving you more flexibility to switch formats or step down to maintenance dosing without changing providers.

PlexusDx includes a named Doctor of Pharmacy (Dr. Jayden Lee, PharmD) and a free 1:1 check-in, but does not advertise 24/7 chat support. If you need round-the-clock clinical access, that may be a gap. If you value committed-term savings, PlexusDx publishes 3-month ($169/month semaglutide, $269/month tirzepatide) and 6-month ($149/month semaglutide, $249/month tirzepatide) rates; Embody's multi-month rates are not published, so you cannot compare them before signing up.

PlexusDx works with licensed 503A compounding pharmacies, the same regulatory category as Embody and most telehealth GLP-1 programs. Neither program offers FDA-approved branded medications (Ozempic, Wegovy, Mounjaro, Zepbound) at these price points.

Methodology and freshness

We captured Embody's pricing and program details on September 4, 2026, and verified checkout prices on July 21, 2026. PlexusDx prices were verified at the same checkout session. Both programs' month-to-month rates are standard ongoing rates, not limited-time offers. Embody's multi-month prepaid rates, if they exist, were not published at the time of capture and are therefore excluded from this analysis.

The 12-month cost figures are our calculations, derived by multiplying the verified month-to-month rates by twelve. The annual savings figures ($1,320 for semaglutide, $720 for tirzepatide) are also our calculations, subtracting PlexusDx's month-to-month total from Embody's month-to-month total. PlexusDx's prepaid per-month equivalents (for example, $149/month over six months) are labeled as such and are our calculations based on the published multi-month rates.

We use standard ongoing rates and prepaid totals only, verified at the dates shown. We did not capture Embody's 6-month guarantee terms in full, only the headline promise; you should confirm refund conditions, return requirements, and any exclusions at Embody's site before relying on the guarantee. Neither program published shipping costs separately; both bundle shipping into the monthly price.

Frequently Asked Questions

Does Embody charge a membership fee?

No. Embody does not charge a membership fee on top of the medication price. Its standard month-to-month rates—$299 for semaglutide, $349 for tirzepatide—cover the provider visit, prescription, medication, and shipping in a single flat monthly charge.

How does Embody's 6-month guarantee work?

Embody advertises a 6-month money-back guarantee, captured at its site in July 2026. We did not capture the full terms, including whether unused medication must be returned, which months are refundable, or whether restocking fees apply. Confirm the complete conditions at Embody's site before relying on the guarantee.

Can I get oral GLP-1 medication through Embody?

No. As of July 2026, Embody offers injection-only semaglutide and tirzepatide. If you want oral administration, you will need to use a different provider. PlexusDx offers oral semaglutide at $289/month and oral tirzepatide at $349/month, both month-to-month rates.

Does PlexusDx offer a money-back guarantee like Embody?

No. PlexusDx does not offer a money-back guarantee of any duration. Its advantage is lower standard rates—$189/month for semaglutide injection and $289/month for tirzepatide injection—and published multi-month prepaid rates that reduce the per-month cost further if you commit to three or six months.

Which program is better if I want 24/7 support?

Embody includes 24/7 clinical chat support as part of its standard offering. PlexusDx includes a named Doctor of Pharmacy and a free 1:1 check-in, but does not advertise round-the-clock chat availability. If you anticipate needing asynchronous clinical access at odd hours, Embody has the explicit advantage; if you prefer scheduled consultations with a named clinician, PlexusDx may be sufficient.

Sources

• Embody pricing and program details, captured September 4, 2026; checkout prices verified July 21, 2026.
• PlexusDx pricing and program details, captured September 4, 2026; checkout prices verified July 21, 2026.
• Embody membership fee and "same price at every dose" statement, captured July 20, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.